Veradigm Stock

Veradigm EBIT

The EBIT of Veradigm (MDRX) as of Jul 22, 2026 is -19.05 M USD. In the previous year, EBIT was 89.00 M USD — a change of -121.41% (lower).

EBIT

-19.05 MUSD

YoY

-121.41%

Last updated:

In 2026, Veradigm's EBIT was -19.05 M USD, a -121.41% increase from the 89.00 M USD EBIT recorded in the previous year.

The Veradigm EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2022
-19.05 base
Jan 1, 2023 (e)
82.69 base
Jan 1, 2024 (e)
46.56 base
Jan 1, 2025 (e)
39.47 base
Jan 1, 2026 (e)
241.03 base
Jan 1, 2027 (e)
141.78 base
Jan 1, 2028 (e)
86.80 base
Jan 1, 2029 (e)
103.94 base
YEAREBIT (M USD)
2029 est 103.94
2028 est 86.80
2027 est 141.78
2026 est 241.03
2025 est 39.47
2024 est 46.56
2023 est 82.69
2022 -19.05
2021 89.00
2020 -56.00
2019 -63.10
2018 -96.70
2017 12.50
2016 72.40
2015 33.40
2014 -36.80
2013 -100.10
2012 24.40
2011 136.50
2010 104.60
2009 45.90
2008 40.20
2007 28.10
2006 19.90
2005 9.20
2004 3.20
2003 -6.30
Access this data via the Eulerpool API

Veradigm Revenue

Veradigm Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
588.02 M USD
-19.05 M USD
-86.46 M USD
Jan 1, 2023 (e)
630.46 M USD
82.69 M USD
80.35 M USD
Jan 1, 2024 (e)
616.66 M USD
46.56 M USD
39.99 M USD
Jan 1, 2025 (e)
596.34 M USD
39.47 M USD
29.44 M USD
Jan 1, 2026 (e)
822.17 M USD
241.03 M USD
60.27 M USD
Jan 1, 2027 (e)
788.26 M USD
141.78 M USD
119.96 M USD
Jan 1, 2028 (e)
656.88 M USD
86.80 M USD
59.98 M USD
Jan 1, 2029 (e)
694.62 M USD
103.94 M USD
74.42 M USD

Veradigm Margins

Veradigm stock margins

The Veradigm margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Veradigm. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Veradigm.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
52.45 %
-3.24 %
-14.70 %
Jan 1, 2023 (e)
52.45 %
13.12 %
12.74 %
Jan 1, 2024 (e)
52.45 %
7.55 %
6.48 %
Jan 1, 2025 (e)
52.45 %
6.62 %
4.94 %
Jan 1, 2026 (e)
52.45 %
29.32 %
7.33 %
Jan 1, 2027 (e)
52.45 %
17.99 %
15.22 %
Jan 1, 2028 (e)
52.45 %
13.21 %
9.13 %
Jan 1, 2029 (e)
52.45 %
14.96 %
10.71 %

Veradigm Stock analysis

What does Veradigm do? Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Veradigm's EBIT

Veradigm's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Veradigm's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Veradigm's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Veradigm’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Veradigm stock

EBIT of Veradigm is -19.05 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Veradigm

All Key Metrics — Veradigm